Cessatech A/S (NGM:CESSA)

Sweden flag Sweden · Delayed Price · Currency is SEK · Price in DKK
19.26
+0.02 (0.10%)
At close: Feb 12, 2026
Market Cap507.59M +59.3%
Revenue (ttm)-6.81M
Net Income-25.68M
EPS-1.42
Shares Out18.58M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,110
Average Volume62,825
Open19.24
Previous Close19.24
Day's Range19.00 - 19.46
52-Week Range6.00 - 26.00
Beta0.76
RSI45.82
Earnings DateFeb 27, 2026

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 4
Stock Exchange Nordic Growth Market
Ticker Symbol CESSA
Full Company Profile

Financial Performance

Financial numbers in DKK Financial Statements